| Methods for population adjustment with limited access to individual patient data: A review and simulation study A Remiro-Azócar, A Heath, G Baio Research Synthesis Methods 12 (6), 750-775, 2021 | 32 | 2021 |
| Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs I van Oostrum, M Ouwens, A Remiro-Azócar, G Baio, MJ Postma, ... Value in Health 24 (9), 1294-1301, 2021 | 29 | 2021 |
| Conflating marginal and conditional treatment effects: Comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation … A Remiro‐Azócar, A Heath, G Baio Statistics in Medicine 40 (11), 2753-2758, 2021 | 20 | 2021 |
| Parametric G-computation for compatible indirect treatment comparisons with limited individual patient data A Remiro-Azócar, A Heath, G Baio Research Synthesis Methods 13 (6), 716-744, 2022 | 19 | 2022 |
| Target estimands for population-adjusted indirect comparisons A Remiro-Azócar Statistics in Medicine 41 (28), 5558-5569, 2022 | 11 | 2022 |
| Two-stage matching-adjusted indirect comparison A Remiro-Azócar BMC Medical Research Methodology 22 (1), 1-16, 2022 | 8 | 2022 |
| Effect modification in anchored indirect treatment comparison: Comments on “Matching-adjusted indirect comparisons: Application to time-to-event data” A Remiro-Azócar, A Heath, G Baio Statistics in Medicine 41 (8), 1541-1553, 2022 | 6* | 2022 |
| Marginalization of Regression-Adjusted Treatment Effects in Indirect Comparisons with Limited Patient-Level Data A Remiro-Azócar, A Heath, G Baio arXiv preprint arXiv:2008.05951, 2020 | 5 | 2020 |
| Transportability of model-based estimands in evidence synthesis A Remiro-Azócar arXiv preprint arXiv:2210.01757, 2023 | 3* | 2023 |
| Population-Adjusted Indirect Treatment Comparisons with Limited Access to Patient-Level Data A Remiro Azócar UCL (University College London), 2022 | 2 | 2022 |
| 1105P Estimating long-term survivorship in patients with advanced melanoma treated with immune-checkpoint inhibitors: Analyses from the phase III CheckMate 067 trial P Mohr, J Larkin, VF Paly, AR Azocar, G Baio, M Kurt, A Amadi, JI Rizzo, ... Annals of Oncology 31, S747, 2020 | 2 | 2020 |
| Methodological considerations for novel approaches to covariate-adjusted indirect treatment comparisons A Remiro-Azócar, A Heath, G Baio Research Synthesis Methods 14 (4), 652-658, 2023 | 1 | 2023 |
| Some considerations on target estimands for health technology assessment A Remiro-Azócar Statistics in Medicine 41 (28), 5592-5596, 2022 | 1 | 2022 |
| PCN193 Assessing the Impact of Modeling Non-Disease-Related Mortality on Long-Term Survivorship Rates in Previously Untreated Advanced Melanoma: A Case Study from CheckMate 067 V Paly, P Mohr, J Larkin, M Middleton, JH Youn, A Remiro-Azocar, G Baio, ... Value in Health 24, S55, 2021 | 1 | 2021 |
| PNS311 PREDICTIVE-ADJUSTED INDIRECT COMPARISON (PAIC): A NOVEL METHOD FOR POPULATION-ADJUSTED INDIRECT COMPARISON AR Azocar, G Baio, A Heath Value in Health 22, S816, 2019 | 1 | 2019 |
| City-wide Mobility Mapping Using Social Media Communications P Adams, A Remiro-Azócar University of Bath, 2016 | 1 | 2016 |
| Model-based standardization using multiple imputation A Remiro-Azócar, A Heath, G Baio BMC Medical Research Methodology 24 (1), 1-15, 2024 | | 2024 |
| HTA118 Estimands in Health Technology Assessments: Methodological Considerations and Recommendations A Morga, A Gorst-Rasmussen, P Polavieja, A Remiro-Azócar, K Rantell, ... Value in Health 26 (12), S341, 2023 | | 2023 |
Gianluca BaioUniversity College LondonVerified email at ucl.ac.uk
